3 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 3, Not yet recruiting 1, Recruiting 1, Unknown 1 |
Follow Respiratory Depression: new trials by email Literature Review of Respiratory Depression trials Research Report on Respiratory Depression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments Remimazolam, Propofol - Postoperative Complications, Respiratory Depression | Phase 4 | Recruiting | Kaohsiung Veterans General Hospital. | 90 | 2025-02-12 | 2025-05-08 |
| Effect of Propofol Versus Remimazolam Intravenous Anesthesia on Respiratory Depression Propofol group, Remimazolam group - Respiratory Depression | Phase 4 | Not yet recruiting | Second Affiliated Hospital of Wenzhou Medical University | 96 | 2025-02-01 | 2025-02-10 |
| Oliceridine in Patients With Acute Burn Injuries Oliceridine, Historical opioid use - Acute Pain, Burns | Phase 4 | Completed | University of Tennessee | 31 | 2023-04-01 | 2023-10-26 |
| Influence of Δ9-tetrahydrocannabinol (THC) on Oxycodone Induced Ventilatory Depression in Healthy Volunteers Medicinal cannabis in combination with oxycodon, Medicinal cannabis in combination with placebo oxycodon - Respiratory Depression, Cannabis Use | Phase 4 | Unknown | Leiden University Medical Center | 20 | 2021-12-09 | 2022-02-11 |
| The Use of Low Dose Prophylactic Naloxone Infusion to Prevent Respiratory Depression With Intrathecal Morphine. Naloxone, Placebo - Respiratory Depression | Phase 4 | Completed | University College Dublin | 96 | 2016-04-01 | 2017-12-19 |
| Effect of Interscalene Block on Ventilatory Function ropivacaine 2 mg/ml - Respiratory Depression, Anesthesia Morbidity | Phase 4 | Completed | Pierre and Marie Curie University | 70 | 2012-01-01 | 2015-01-19 |
Respiratory Insufficiency (6) · Postoperative Nausea and Vomiting (2) · Acute Pain (1) · Bites and Stings (1) · Burns (1) · Constipation (1) · Drug-Related Side Effects and Adverse Reactions (1) · Postoperative Complications (1) · Vomiting (1)
Respiration Disorders (6) · Respiratory Tract Diseases (6) · Chemically-Induced Disorders (2) · Nausea (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Signs and Symptoms, Digestive (2) · Wounds and Injuries (2) · Neurologic Manifestations (1) · Pain (1) · Poisoning (1) · Postoperative Complications (1) · Vomiting (1)
((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine (1) · Medical Marijuana (1) · Naloxone (1) · Propofol (1) · Ropivacaine (1) · remimazolam (1)
Kaohsiung Veterans General Hospital. (1) · Leiden University Medical Center (1) · Pierre and Marie Curie University (1) · Second Affiliated Hospital of Wenzhou Medical University (1) · University College Dublin (1) · University of Tennessee (1)
China (1) · France (1) · Ireland (1) · Netherlands (1) · Taiwan (1) · United States (1)
Huacheng Liu (1) · Monique van Velzen, Phd (1) · Peter Doran, PhD (1) · Philippe Cuvillon, Md,PhD (1) · Tzung-Jim Tsai, M.D (1) · Yuhang Cai (1)
PMID 11475180, PMID 20407252, PMID 22272061, PMID 23635608, PMID 24937564, PMID 26609095, PMID 29284510, PMID 29630212, PMID 29723512, PMID 30522856, PMID 31557307, PMID 31792949, PMID 36764022, PMID 37730240, PMID 38039392, PMID 38261005, PMID 38305707, PMID 38443286